These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7365015)

  • 21. Bolus injection v drip infusion contrast administration for ureteral stone targeting during shockwave lithotripsy.
    Pearle MS; McClennan BL; Roehrborn CG; Clayman RV
    J Endourol; 1997 Jun; 11(3):163-6. PubMed ID: 9181442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrocardiographic changes following intravenous pyelography.
    Listchinsky M; Wanderman KL; Ovsyshcher I; Gueron M
    Isr J Med Sci; 1975 Apr; 11(4):304-7. PubMed ID: 1095528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostacyclin (PGI2) and thromboxane (TXA2) levels during intravenous contrast medium administration in CT.
    Paajanen H; Kormano M
    Eur J Radiol; 1985 Aug; 5(3):243-5. PubMed ID: 3896802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic study of theophylline in dogs after intravenous administration with and without ethylenediamine.
    Kawai H; Kokubun S; Matsumoto T; Kojima J; Onodera K
    Methods Find Exp Clin Pharmacol; 2000 Apr; 22(3):179-84. PubMed ID: 10893702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intra-arterial bolus of 125I labeled meglumine diatrizoate. Early extravascular distribution.
    Dean PB; Kormano M
    Acta Radiol Diagn (Stockh); 1977 Jul; 18(4):425-32. PubMed ID: 920233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iotroxamide studies in man--biliary iodine levels following bolus injection and slow infusion. Comparison with ioglycamide.
    Doran J; Jarrett LN; Bell GD
    Clin Radiol; 1980 Nov; 31(6):651-5. PubMed ID: 7214804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lanreotide effect on splanchnic blood flow in healthy subjects: effect of the rate of infusion.
    Sieber CC; Beglinger C; Bart S; Tschoepl M; Currie G; Larsen F; Drewe J
    Clin Pharmacol Ther; 2004 Jan; 75(1):70-9. PubMed ID: 14749693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue diffusion of doxycycline in rats: a comparison between intravenous bolus injection or drip-infusion.
    Miglioli PA
    Chemioterapia; 1988 Jun; 7(3):156-9. PubMed ID: 3168070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of the mode of intravenous administration on cephotaxime concentration in bile. A comparison of bolus, drip infusion and bolus plus drip infusion.
    Miglioli PA; Tedeschi U
    Chemotherapy; 1988; 34(5):380-4. PubMed ID: 3180906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphatic distribution of intravenous radiographic contrast media.
    Hegedüs V; Cramer BM; Cockett AT
    Invest Radiol; 1974; 9(2):56-60. PubMed ID: 4823539
    [No Abstract]   [Full Text] [Related]  

  • 31. Abuse of recombinant human growth hormone: studies in two different dog models.
    Rigamonti AE; Scanniffio D; Bonomo SM; Cella SG; Sartorio A; Müller EE
    Neuroendocrinology; 2004; 79(5):237-46. PubMed ID: 15218318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue concentrations of mezlocillin in benign hypertrophy of the prostate following intravenous bolus injection versus infusion.
    Naber KG; Adam D
    J Antimicrob Chemother; 1983 May; 11 Suppl C():17-23. PubMed ID: 6194144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the effect of continuous intravenous infusion and two bolus injections of remifentanil on haemodynamic responses during anaesthesia induction: a prospective randomised single-centre study.
    Maruta T; Kodama Y; Tanaka I; Shirasaka T; Tsuneyoshi I
    BMC Anesthesiol; 2016 Nov; 16(1):110. PubMed ID: 27842499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of dose regimens for the administration of recombinant pro-urokinase in a canine thrombosis model.
    Burke SE; Lubbers NL; Nelson RA; Henkin J
    Thromb Haemost; 1997 May; 77(5):1025-30. PubMed ID: 9184422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A strategy for the contrast enhancement of malignant tumors using dynamic computed tomography and intravascular pharmacokinetics.
    Young SW; Turner RJ; Castellino RA
    Radiology; 1980 Oct; 137(1 Pt 1):137-47. PubMed ID: 7422835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Bolus geometry and dynamics after intravenous injections of contrast media Studies using chronography].
    Claussen CD; Linke G; Felix R; Lochner B; Weinmann HJ; Wegener OH
    Rofo; 1982 Aug; 137(2):212-6. PubMed ID: 6215308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drip infusion pyelography.
    Wendth AJ
    Am J Roentgenol Radium Ther Nucl Med; 1965 Oct; 95(2):269-82. PubMed ID: 5832174
    [No Abstract]   [Full Text] [Related]  

  • 38. Contrast-medium-induced electrocardiographic abnormalities: comparison of bolus and infusion of methylglucamine iodamide and methylglucamine/sodium diatrizoate.
    Pfister RC; Hutter AM; Newhouse JH; Yoder IC; Travers E
    AJR Am J Roentgenol; 1983 Jan; 140(1):149-53. PubMed ID: 6600306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of intravenous drug administration mode on drug distribution in a tumor slab: a finite Fourier transform analysis.
    Subramaniam B; Claudius JS
    J Theor Biol; 1990 Mar; 143(1):55-76. PubMed ID: 2359318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The diagnostic potential of contrast enhancement pharmacokinetics.
    Dean PB; Kivisaari L; Kormano M
    Invest Radiol; 1978; 13(6):533-40. PubMed ID: 755032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.